Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

NCT ID: NCT01784497

Last Updated: 2014-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This Study Aims to Evaluate:-

1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.
2. Impact of post transplant medical and psychiatric complications on quality of life

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Related Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recipients of Living Donor Liver Transplantation

Patients who will undergo Living Donor Liver Transplantation (LDLT) In Ain Shams Center For Organ Transplantation (ASCOT) .

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult Egyptian patients
* 18-60 years old
* Patients transplanted for HCV related disease and /or HCC
* Informed consent

Exclusion Criteria

* Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Iman Fawzy Montasser

Lecturer of tropical medicine , Ain Shams university

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PostTransplant Quality of life

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hepatic Excision and Ablation Log
NCT06870461 NOT_YET_RECRUITING
Nomogram for Predicting Biliary Complication
NCT06658665 NOT_YET_RECRUITING